231 related articles for article (PubMed ID: 20735222)
1. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects.
Tang H; Murphy CJ; Zhang B; Shen Y; Sui M; Van Kirk EA; Feng X; Murdoch WJ
Nanomedicine (Lond); 2010 Aug; 5(6):855-65. PubMed ID: 20735222
[TBL] [Abstract][Full Text] [Related]
2. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
Shen Y; Jin E; Zhang B; Murphy CJ; Sui M; Zhao J; Wang J; Tang J; Fan M; Van Kirk E; Murdoch WJ
J Am Chem Soc; 2010 Mar; 132(12):4259-65. PubMed ID: 20218672
[TBL] [Abstract][Full Text] [Related]
4. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
5. Curcumin polymers as anticancer conjugates.
Tang H; Murphy CJ; Zhang B; Shen Y; Van Kirk EA; Murdoch WJ; Radosz M
Biomaterials; 2010 Sep; 31(27):7139-49. PubMed ID: 20591475
[TBL] [Abstract][Full Text] [Related]
6. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.
Yin H; Zhang H; Liu B
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):634-40. PubMed ID: 23786839
[TBL] [Abstract][Full Text] [Related]
7. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
8. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
[TBL] [Abstract][Full Text] [Related]
9. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
10. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.
Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S
Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
12. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
13. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin enhances curcumin's cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptake.
Klippstein R; Bansal SS; Al-Jamal KT
Int J Pharm; 2016 Nov; 514(1):169-175. PubMed ID: 27863661
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
16. Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice.
Guorgui J; Wang R; Mattheolabakis G; Mackenzie GG
Arch Biochem Biophys; 2018 Jun; 648():12-19. PubMed ID: 29679536
[TBL] [Abstract][Full Text] [Related]
17. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
19. Co-Delivery of Triptolide and Curcumin for Ovarian Cancer Targeting Therapy via mPEG-DPPE/CaP Nanoparticle.
Liu L; Xiong X; Shen M; Ru D; Gao P; Zhang X; Huang C; Sun Y; Li H; Duan Y
J Biomed Nanotechnol; 2018 Oct; 14(10):1761-1772. PubMed ID: 30041722
[TBL] [Abstract][Full Text] [Related]
20. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
